Interview with Nihal Aygun, CEO, Corena Turkey
Mrs Aygun, could you please introduce yourself to our readers and give us an overview of CORENA? I have an educational background in chemistry and a professional experience in several…
Address: 2545. Sokak Toyko Villalari No:14 Umitkoy / Yenimahalle / Ankara / TURKEY
2545. Sokak Toyko Villalari No:14 Umitkoy / Yenimahalle / Ankara / Turkey
Tel: +90 312 236 43 34
Web: http://www.corena.com.tr/
CORENA has been successfully serving to its clients worldwide since 1998 with an overall focus to help clients locate new areas of expansion within the marketplace, to implement best practices for achieving success and to achieve high growth levels in these areas of opportunity. With our extensive geographic coverage we are committed to consistently striving to deliver relevant tailored solutions,
Authenticity, happiness, passion, commitment and responsibility are the key words in the daily life of our company…
FIELD OF ACTIVITIES
INTERNATIONAL SALES
CLINICAL TRIALS
Weprovide governments, multilateral and procurement agencies, non-governmental organisations, charities, missionary groups, pharmaceutical wholesalers, hospitals and retail chemistsin 53 differentcountrieswithwiderangeof productssuch as:
PHARMACEUTICALS
OTC PRODUCTS
VACCINES
MEDICAL DEVICES
COSMETICS
DIET PRODUCTS
VETERINARIAN PRODUCTS
DIAGNOSTICS
CLINICAL TRIALS
CORENA dispatchesproductstoclinicaltrial centres across the worldwiththebestdeliveryconditonssuch as:
Cold chain and ambient supply chain
Fully tracked deliveries including temperature control
Specialized andExperienced Team
CORENA’S DIFFERENCE
With 15 yearsexperiece of sourcingquality- assuredandreliableproducts, wehavebeenabletobuildupstrong global supplierrelationship,andyou can alwaysdepend on thequality of CORENA’sproducts, BECAUSE WE DIFFER FROM THE OTHERS IN MANY ASPECTS SUCH AS:
OFFERINGS
LOGISTICS
SECURITY
LICENCES
CONFIDENTIALTY
EXPERIENCED AND SPECIALIZED TEAM
OUR OFFERINGS
Whereveryouare,operateorwork, our experienced multi-lingual team are able to source pharmaceuticals and other medical products for you in any quantity at any time and at any competitive price.
Weoffer awiderange of packagingoptionsincludingvalidatedboxesandmaterialsforcoldchainandhazardousitems.
Wearealsoquiteeffectivewiththeshipment of theorders. 90 % of yourproductsaredispatchedwithin 3-4 daysdays. As forthe life-savingmedicineswe do ourbesttosendthem on thesameday.
STORAGE
Temperature of theproducts is monitored and recorded periodically. The records of temperature are reviewed regularly.
Storage facilities arealwaysclean and free from litter, dust and pests.
Adequate precautions aretaken against spillage or breakage, attack by micro-organisms and cross contamination.
There is a system to ensure stock rotation (‘first in first out’) with regular and frequent checks that the system is operating correctly.
Products beyond their expiry date or shelf life are separated from usable stock and neither sold nor supplied.
Medicinal products with broken seals, damaged packaging, or suspected of possible contamination arewithdrawn from saleable stock, and if not immediately destroyed, they arekept in a clearly separated area in order not to be soldbe sold mistakenly, ortoavoidthecontamination o otherproducts.
LOGISTICS
CORENA will manage your shipment and ensure that your goods arrive in the best conditions at the right time and place, and with all correct documentation.
We offer:
• Delivery within 3-4 daysfor most products depending on destination
• Specialist packaging to ensure perfect condition on arrival including temperature sensitive, dangerous/hazardous and fragile
• Competitive freight alternatives around the world
COLD CHAIN
We frequently ship to over 53 countries and our specialist logistics team ensures deliveries go out on time from our fully licensed warehouse.
Cold chain deliveries:
CORENA has extensive experience in shipping temperature-sensitive goods across the globe using either refrigerated transport or insulated packaging.
We have full SOPs to cover all elements of temperature-sensitive transport and these are available for inspection by our clients. CORENA uses temperature boxes and tracks all shipments using temperature loggers. We are, of course, willing to abide by any trial protocols and use differing technologies if necessary.
Mrs Aygun, could you please introduce yourself to our readers and give us an overview of CORENA? I have an educational background in chemistry and a professional experience in several…
PharmaBoardroom talked to Sr. Managing Director of Medtronic Turkey, Ayhan Ozturk about improving patient outcomes, how the company introduced a whole new standard on integrated healthcare, and their recent USD $25 million…
Umut Gökalp, managing director of Japan’s Sysmex in Turkey – a company specialising in in-vitro diagnostics – evaluates their approach to developing business opportunities in the Turkish medical device sector. He also…
Sevi Firat, Founding Partner of Firat Izgi discusses the legal challenges facing pharmaceutical companies looking to penetrate the healthcare market in Turkey, the evolution of the legal landscape and her…
Tuğçe Koç describes the company’s initial aspirations in targeting the higher value-added therapeutic area of oncology and the type of market opportunities that are present domestically and internationally. With over…
A founding partner of YükselKarkınKüçük, Gökhan Gökçe discusses the firm’s involvement with several high profile cases concerning the healthcare and life science sector’s reference pricing system, and also elaborates on…
The managing director of DHL Express Turkey, Markus Reckling highlights the strategic importance of Turkey to the global DHL Express portfolio and elaborates on the market opportunities present for DHL’s…
The co-founder of Ekin Kimya discusses the need for greater regulation and monitoring of raw materials used in Turkish pharmaceutical manufacturing, his company’s key role as an educator and advisor…
Novartis country president Peter Catalino discusses the need for Turkey to introduce financial investment incentives to compete more effectively with other countries for investments in R&D and manufacturing. You arrived…
The chairman and CEO of Santa Farma discusses how the Turkish pharmaceutical landscape has evolved in response to the government’s healthcare transformation programs. He also enumerates various strategic initiatives the…
Omega CRO has evolved from its beginnings as a CRO contracted by local and multinational pharmaceutical companies into an organization leading clinical, epidemiological and observational studies of public interest across…
The president of the Turkish Drug and Medical Device Agency (TITCK) discusses new initiatives and reforms being carried out by his agency, including its work towards becoming a PIC/s member, and…
The CEO of Centurion shares his ambitious vision for the company’s expansion into plasma products, biotech, orphan drugs, and generic injectables over the coming years, while simultaneously developing sales in more than…
See our Cookie Privacy Policy Here